Mitochondrial dysfunction in diabetic tubulopathy

Metabolism. 2022 Jun:131:155195. doi: 10.1016/j.metabol.2022.155195. Epub 2022 Mar 28.

Abstract

Diabetic kidney disease (DKD) is a devastating microvascular complication associated with diabetes mellitus. Recently, the major focus of glomerular lesions of DKD has partly shifted to diabetic tubulopathy because of renal insufficiency and prognosis of patients is closely related to tubular atrophy and interstitial fibrosis. Indeed, the proximal tubule enriching in mitochondria for its high energy demand and dependence on aerobic metabolism has given us pause to focus primarily on the mitochondria-centric view of early diabetic tubulopathy. Multiple studies suggest that diabetes condition directly damages renal tubules, resulting in mitochondria dysfunction, including decreased bioenergetics, overproduction of mitochondrial reactive oxygen species (mtROSs), defective mitophagy and dynamics disturbances, which in turn trigger a series of metabolic abnormalities. However, the precise mechanism underlying mitochondrial dysfunction of renal tubules is still in its infancy. Understanding tubulointerstitial's pathobiology would facilitate the search for new biomarkers of DKD. In this Review, we summarize the current literature and postulate that the potential effects of mitochondrial dysfunction may accelerate initiation of early-stage diabetic tubulopathy, as well as their potential therapeutic strategies.

Keywords: Diabetic kidney disease; Diabetic tubulopathy; Mitochondrial dysfunction; Renal proximal tubule injury.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Diabetes Mellitus* / metabolism
  • Diabetic Nephropathies* / metabolism
  • Female
  • Humans
  • Kidney Tubules / metabolism
  • Kidney Tubules, Proximal / metabolism
  • Male
  • Mitochondria / metabolism
  • Reactive Oxygen Species / metabolism

Substances

  • Reactive Oxygen Species